KAKKIS EMIL D

RARE

KAKKIS EMIL D serves as President & CEO at Ultragenyx Pharmaceutical Inc. (RARE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

10 trades

$15.70M

Net Position

Net Seller

$15.70M

Companies Traded

RARE

Active Period

May 2021 – Feb 2025

10 total trades

Most Recent

Sell RARE

Feb 28, 2025 · $4.15M

KAKKIS EMIL D's Insider Trading at Ultragenyx Pharmaceutical Inc. (RARE)

Buys

0 · $0.00

Sells

10 · $15.70M

Total Shares Bought

Total Shares Sold

315,869

RARE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 28, 2025	Sell	98,434	$42.20	$4.15M	0
Dec 31, 2024	Sell	11,727	$42.23	$495.2K	2,183,985
Dec 11, 2024	Sell	8,273	$50.00	$413.6K	2,195,712
Sep 5, 2024	Sell	20,000	$55.85	$1.12M	2,223,985
Aug 7, 2024	Sell	20,000	$50.17	$1.00M	2,243,985
Feb 8, 2024	Sell	30,000	$45.00	$1.35M	539,770
Jan 2, 2024	Sell	30,000	$47.87	$1.44M	569,770
Oct 23, 2023	Sell	47,853	$33.52	$1.60M	599,743
Jan 3, 2023	Sell	19,582	$45.57	$892.4K	541,108
May 5, 2021	Sell	30,000	$107.80	$3.23M	2,259,741